Jim Cramer says SpaceX investors aren't buying earnings — they're buying Elon Musk

SpaceX’s valuation surged above $2.5 trillion after its blockbuster IPO, with shares up nearly 5% Tuesday and briefly overtaking Microsoft. Jim Cramer argued investors are paying for Elon Musk’s ability to build transformative businesses rather than near-term earnings, citing Starlink, reusable rockets, long-term data center ambitions, and the $60 billion stock acquisition of AI coding startup Cursor. The article is supportive of sentiment toward SpaceX, though it also underscores major valuation risk given losses and ambitious revenue forecasts.

Analysis

The market is assigning a platform multiple to an asset that still looks more like a venture-style call option than a cash-flow compounder. That matters because the near-term driver is not fundamental earnings, but incremental liquidity and a reflexive narrative loop: every print higher forces benchmark-chasing and retail FOMO, which can keep valuation detached far longer than skeptics expect. The setup resembles a private-market scarcity trade more than a public-equity valuation exercise, so traditional comparables remain a poor anchor.

The bigger second-order effect is competitive: if this trade works, it lowers the implied cost of capital for any “founder-as-a-flag” ecosystem and pressures listed tech giants to justify themselves on growth optionality rather than current margins. BRK.B is the cleaner public-market analog in terms of personality premium, but unlike Berkshire, this story still depends heavily on a single operator and unresolved execution across multiple capital-intensive fronts. That concentration increases both upside convexity and governance/key-man risk.

The main reversal catalyst is not a single bad quarter; it is a sequence of delayed monetization signals over 6-18 months: capex intensity staying elevated, margin dilution from adjacent bets, or a broader risk-off regime that reduces tolerance for long-duration narratives. The most likely underappreciated risk is that the market is already discounting several future businesses before product-market fit is proven, leaving little room for disappointment if any one growth vector slips. If momentum stalls, the unwind could be fast because positioning is likely crowded and sentiment-driven rather than fundamental.

Contrarianly, the move may still be underdone in the very near term if flows remain the dominant marginal buyer and there is no public-market substitute for this kind of founder optionality. But from a 12-month lens, the asymmetry is worse for late entrants: the upside from here is mostly multiple expansion on belief, while the downside includes a multi-hundred-billion reset if the ‘Musk premium’ gets questioned. That makes this a trade to own tactically, not a name to underwrite on static valuation.

Key Decisions for Investors

• Avoid initiating fresh long exposure in AMZN/MSFT on the headline; relative multiple compression can persist if capital rotates into founder-optionality names over the next 1-3 months.
• Long BRK.B / short a high-beta basket of large-cap tech sentiment names over 3-6 months; if the market is rewarding personality premium, Berkshire is the cleaner, lower-volatility proxy with less key-man risk.
• Sell upside volatility on AMZN or MSFT only if implieds remain elevated after the move; use 30-60 day call overwrites to monetize crowded growth-beta demand while limiting mark-to-market risk.
• For aggressive accounts, structure a tactical short-dated put spread in the most valuation-sensitive mega-cap tech names if risk appetite weakens; thesis is a 2-4 week de-rating once the market refocuses on cash returns.
• Set a 6-12 month alert on any evidence of delayed monetization or rising execution costs in adjacent AI/platform initiatives; that is the trigger to fade the ‘founder premium’ trade rather than chase it.